Filing Details
- Accession Number:
- 0001209191-21-053374
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-25 19:32:07
- Reporting Period:
- 2021-08-24
- Accepted Time:
- 2021-08-25 19:32:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1029142 | Dynavax Technologies Corp | DVAX | Pharmaceutical Preparations (2834) | 330728374 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1812025 | Justin Burgess | C/O Dynavax Technologies 2100 Powell Street, Suite 900 Emeryville CA 94608 | Principal Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-08-13 | 2,500 | $3.39 | 9,489 | No | 4 | A | Direct | |
Common Stock | Disposition | 2021-08-24 | 5,768 | $15.00 | 3,721 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents 2,500 shares acquired under Issuer's 2014 Employee Stock Purchase Plan (ESPP) on August 13, 2021.
- The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on March 11, 2021.
- All shares were sold at $15.00.